[HTML][HTML] Use of pharmacogenomics in pediatric renal transplant recipients
M Medeiros, G Castañeda-Hernández… - Frontiers in …, 2015 - frontiersin.org
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
[PDF][PDF] Use of pharmacogenomics in pediatric renal transplant recipients
M Medeiros, G Castañeda-Hernández, CJD Ross… - core.ac.uk
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
[HTML][HTML] Use of pharmacogenomics in pediatric renal transplant recipients
M Medeiros, G Castañeda-Hernández… - Frontiers in …, 2015 - ncbi.nlm.nih.gov
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
[PDF][PDF] Use of pharmacogenomics in pediatric renal transplant recipients
M Medeiros, G Castañeda-Hernández, CJD Ross… - researchgate.net
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
Use of pharmacogenomics in pediatric renal transplant recipients
M Medeiros, G Castañeda-Hernández… - Frontiers in …, 2015 - pubmed.ncbi.nlm.nih.gov
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
[PDF][PDF] Use of pharmacogenomics in pediatric renal transplant recipients
M Medeiros, G Castañeda-Hernández, CJD Ross… - cyberleninka.org
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
Use of pharmacogenomics in pediatric renal transplant recipients.
M Medeiros, G Castañeda-Hernández, CJ Ross… - Frontiers in …, 2015 - europepmc.org
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
Use of pharmacogenomics in pediatric renal transplant recipients.
M Medeiros, G Castañeda-Hernández, CJ Ross… - Frontiers in …, 2015 - europepmc.org
Transplant recipients receive potent immunosuppressive drugs in order to prevent graft
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …
rejection. Therapeutic drug monitoring is the current approach to guide the dosing of …